Table 2.
Peptide | Sequence
|
Kd (μM) | Fold versus Model a |
---|---|---|---|
P−7-P−6-P−5-P−4-P−3-P−2-P−1-P0 | |||
Consensus Model | Ac-SSRKEYYA | 112±15b | |
Syndecanl | dan-TKQEEFYA | 26.9±0.9 | 4.2 |
Syndecan1 (phos) | dan-TKQEEFYpA | 19.3±1.5 | 5.8 |
Syndecan1 (A→F) | dan-TKQEEFYF | 55.7±3.6 | 2.0 |
Caspr4 | dan-ENQKEYFF | 16.8±5.4 | 6.7 |
Caspr4 (F→A) | dan-ENQKEYFA | 64.8±5.9 | 1.7 |
Neurexin1 | Ac-NKDKEYYV | 2400±250b | 0.05 |
dan, dansyl moiety; Ac, acetylated.
Fold versus Model refers to Kd (Model)/Kd (peptide).
Affinity determined by NMR titration.